NCT01310881View on ClinicalTrials.gov

Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189

PHASE1CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Depression

Interventions

DRUG

NSI-189 Phosphate

Once daily oral administration

Trial Locations (1)

91206

California Clinical Trials, Glendale

Sponsors

Lead Sponsor

Neuralstem Inc.

All Listed Sponsors

lead

Neuralstem Inc.

INDUSTRY